Day 1 - Monday, April 25, 2016

7:00
Registration and Continental Breakfast
8:00
Co-Chairs’ Opening Remarks
8:15
Pharmaceutical Patent Invalidity Challenge Score Card: District Courts v. The PTAB
9:15
Paragraph IV Jurisdictional Show-Down at the Federal Circuit: Determining Where a Hatch-Waxman Case Can Be Filed in the Aftermath of Daimler and Mylan
10:15
Networking Break
10:30
The Safe Harbor: Defining Boundaries and Preparing for New Ancillary Storms
11:30
On Sale Bar in a Hatch-Waxman Setting: Analyzing Patent Impediments Caused by Contract Manufacturing and Its Impact on Pharmaceutical Product Market Access
12:15
Networking Luncheon
1:30
The Evolving 101 Challenge: How Subject Matter Patentability Has Become the “Next Big Thing” in Hatch-Waxman Related Invalidity Challenges
2:30
Networking Break
2:50
Parallel Proceedings Moot Court: District Court and PTAB Mock Pharmaceutical Patent Invalidity Hearing
4:05
The PTAB Live
4:50
A View From the U.S. District Court Bench
6:00
Conference Adjourns to Day Two

Day 2 - Tuesday, April 26, 2016

7:00
Continental Breakfast
8:00
Co-Chairs’ Opening Remarks and Recap of Day One
8:15
In the Limelight: Examining Lilly v. Teva and Its Larger Implications for Divided and Induced Infringement in a Hatch- Waxman Setting
9:15
Revisiting Obviousness in the Hatch- Waxman Realm: Prior Art, Obvious- Type Double Patenting, Inherency by Anticipation and PTAB Findings
10:15
Networking Break
10:30
Re-Evaluating Claim Construction and Markman Strategies Post-Teva
11:15
FTC Keynote: Reverse Payment Settlements and Other Antitrust Concerns Impacting Paragraph IV Litigation in the Wake of Actavis
12:00
Networking Luncheon
1:00
Settlement Anthology: A Review of Pharmaceutical Patent Settlement Jurisprudence Since Actavis and Its Practical Applications
2:00
FDA Update: Survey of Latest FDA Developments Impacting Paragraph IV Litigation
2:45
Networking Break
3:00
Risky Business: Examining New Guidance for Calculating Damages in the Aftermath of an At-Risk Launch
4:00
Ethical Considerations in Paragraph IV Practice
5:00
Conference Concludes